SARTORIUS STED BIO (EPA:DIM) | Finanzwire

Basculer en Français

8302	Companies
115121	Keywords
55446	Articles
62530	Press releases

Home
Companies
SARTORIUS STED BIO

PRESS RELEASE

published on 05/02/2024 at 15:34, 6 months 19 days ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA declares the number of shares and voting rights comprising the issued capital as of April 30, 2024

Voting Rights Shares Sartorius Stedim Biotech SA Issued Capital French Regulatory News
BRIEF

published on 04/18/2024 at 07:07, 7 months 3 days ago

Sartorius Stedim Biotech reveals its results for the first quarter of 2024

Financial Results Biopharmaceutical Global Market Taking Orders Economic Projections
PRESS RELEASE

published on 04/18/2024 at 07:02, 7 months 3 days ago

Sartorius Stedim Biotech publishes unaudited first quarter results for 2024
Sartorius Stedim Biotech publishes unaudited first quarter results for 2024, showing sales revenue of 667 million euros and order intake up 13.9 percent. Full-year outlook confirmed amidst global uncertainties

Order Intake Sartorius Stedim Biotech Sales Revenue First Quarter Results Full-year Outlook
BRIEF

published on 04/02/2024 at 15:40, 7 months 19 days ago

Sartorius Stedim Biotech announces its capital structure and voting rights for March 2024

Share Capital Voting Rights Actions Transparency Sartorius Stedim Biotech
PRESS RELEASE

published on 04/02/2024 at 15:35, 7 months 19 days ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA declares the number of shares and voting rights in the issued capital as of March 31, 2024. This announcement complies with relevant regulatory requirements

Voting Rights Shares Sartorius Stedim Biotech SA Regulatory Announcement Issued Capital
BRIEF

published on 03/26/2024 at 16:23, 7 months 26 days ago

Resolutions Passed at Sartorius Stedim Biotech's Annual Shareholders’ Meeting

Board Of Directors Dividend Sartorius Stedim Biotech Biopharmaceutical Industry Annual Shareholders’ Meeting
PRESS RELEASE

published on 03/26/2024 at 16:18, 7 months 26 days ago

Resolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech S.A. shareholders approve resolutions and dividend proposal at Annual Shareholders' Meeting. Board composition updated

Dividend Proposal Sartorius Stedim Biotech S.A. Resolutions Annual Shareholders' Meeting Board Composition
BRIEF

published on 03/01/2024 at 14:27, 8 months 20 days ago

Sartorius Stedim Biotech SA updates its share capital and voting rights

Share Capital Voting Rights Biotechnology Actions Sartorius Stedim Biotech
BRIEF

published on 03/01/2024 at 14:27, 8 months 20 days ago

Sartorius Stedim Biotech SA Updates on Shares and Voting Rights

Voting Rights Shares Sartorius Stedim Biotech Regulatory Announcement Issued Capital
PRESS RELEASE

published on 03/01/2024 at 14:22, 8 months 20 days ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA declares the number of shares and voting rights in its issued capital as of February 29, 2024

Voting Rights Shares Sartorius Stedim Biotech SA Issued Capital French Regulatory News

Accesswire

Published on 11/21/2024 at 22:05, 29 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 44 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 2 hours 19 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 2 hours 24 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 20:00, 2 hours 34 minutes ago

Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 3 hours 33 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 3 hours 58 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 4 hours 36 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 4 hours 43 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 4 hours 43 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.

Les Echos

Published on 11/21/2024 at 06:58, 15 hours 36 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 3 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 4 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 4 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 14 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE